Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M362Revenue $M4.4Net Margin (%)-865.5Z-Score-3.2
Enterprise Value $M386EPS $-0.8Operating Margin %-1,248.5F-Score3
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-1,247.6Higher ROA y-yN
Price/Book39.510-y EBITDA Growth Rate %30.2Quick Ratio1.7Cash flow > EarningsY
Price/Sales50.45-y EBITDA Growth Rate %52.8Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-84.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-299.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M83.1ROI % (ttm)-119.2Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BTX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Russell Angus C.Director 2014-12-12Sell0$0view
Cartt Stephen LaHueDirector 2014-11-04Sell0$0view
SCHLACHET DAVIDDirector 2014-10-08Buy32,050$3.1237.82view
FARRELL STEPHEN CDirector 2014-10-08Buy32,050$3.1237.82view
Peabody RobertSr. VP, COO, and CFO 2014-07-22Sell100,000$2.6562.26view
WEST MICHAEL DCEO 2014-07-22Sell270,000$2.6562.26view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-07-22Buy370,000$2.6562.26view
TEW WILLIAM P PHDChief Commercial Officer 2014-06-17Sell30,000$3.0740.07view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-06-16Buy1,000,000$2.572view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-05-16Buy300,000$2.4575.51view

Press Releases about BTX :

    Quarterly/Annual Reports about BTX:

    News about BTX:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
    Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 

    More From Other Websites
    BioTime Announces First Patient Treated in Pivotal Clinical Trial of Renevia™ for HIV-Associated... Mar 02 2015
    ESI BIO – A Division of BioTime, Inc., Announces Alliance Agreement with Pivotal Scientific Ltd... Mar 02 2015
    LifeMap Sciences Partners with Toldot Genetics to Support Next Generation Sequencing Variant... Mar 02 2015
    BioTime Announces First Patient Treated in Pivotal Clinical Trial of Renevia™ for HIV-Associated... Feb 24 2015
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Feb 24 2015
    Cell Cure Neurosciences Ltd. Provides Update on its Product Development and Partnering Activities Feb 17 2015
    Cell Cure Neurosciences Ltd. Provides Update on its Product Development and Partnering Activities Feb 17 2015
    BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Feb 17 2015
    Asterias Biotherapeutics Completes Public Offering and Private Placement of Common Stock Feb 10 2015
    BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Feb 06 2015
    OncoCyte to Present Cancer Diagnostic Clinical Study Data at AACR Annual Meeting Feb 06 2015
    OncoCyte to Present Cancer Diagnostic Clinical Study Data at AACR Annual Meeting Feb 06 2015
    Asterias Biotherapeutics Prices Public Offering of Common Stock Feb 05 2015
    Asterias Biotherapeutics Announces Public Offering of Common Stock Feb 04 2015
    ESI BIO - A Division of BioTime, Inc. Announces New UK Distribution Agreement with 2BScientific Feb 04 2015
    LifeMap Sciences Announces Partnership with Advaita and Commercial Availability of Advaita’s... Feb 04 2015
    BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell... Jan 26 2015
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Jan 26 2015
    BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell... Jan 26 2015
    LifeMap Sciences, a Subsidiary of BioTime, Announces Release of VarElect, the Next Generation... Jan 15 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK